Anti-proliferative synergy of lysophospholipid analogues and ketoconazole against Trypanosoma cruzi (Kinetoplastida: Trypanosomatidae): cellular and ultrastructural analysis
Open Access
- 1 May 2005
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Antimicrobial Chemotherapy
- Vol. 55 (5) , 780-784
- https://doi.org/10.1093/jac/dki087
Abstract
Objectives: Investigation of the antiproliferative synergy of the lysophospholipid analogues (LPAs) edelfosine, ilmofosine and miltefosine with the ergosterol biosynthesis inhibitor ketoconazole against Trypanosoma cruzi. Methods: The effect of LPAs, ketoconazole and their combination was evaluated against epimastigotes and intracellular amastigotes by the parameter IC50 leading to construction of isobolograms, for determination of a synergic effect. For epimastigotes, ultrastructural damage induced by these treatments was evaluated by transmission and scanning electron microscopy. Results: Synergy was confirmed against both epimastigotes and amastigotes of the parasite. Edelfosine or ketoconazole alone induced morphological alterations in the plasma membrane and reservosomes of the parasites, while in combination, they also led to severe mitochondrial damage, formation of autophagic structures and multinucleation. Scanning electron microscopy confirmed the effect at the plasma membrane and also revealed alterations in the shape of the parasites. Conclusions: Our results describe the synergic anti-proliferative effect of LPAs and ketoconazole against epimastigotes and intracellular amastigotes and suggest that in epimastigotes, plasma membrane, reservosomes and mitochondria are targets of these drugs, possibly by interference with lipid metabolism.Keywords
This publication has 15 references indexed in Scilit:
- In Vitro and In Vivo Activities of E5700 and ER-119884, Two Novel Orally Active Squalene Synthase Inhibitors, against Trypanosoma cruziAntimicrobial Agents and Chemotherapy, 2004
- Antiprotozoal Lysophospholipid Analogues: A Comparison of their Activity Against Trypanosomatid Parasites and Tumor CellsMini-Reviews in Medicinal Chemistry, 2004
- Isolation and characterization of a reservosome fraction fromTrypanosoma cruziFEMS Microbiology Letters, 2002
- A Critical Review on Chagas Disease ChemotherapyMemórias do Instituto Oswaldo Cruz, 2002
- Mechanism of action of anti-proliferative lysophospholipid analogues against the protozoan parasite Trypanosoma cruzi: potentiation of in vitro activity by the sterol biosynthesis inhibitor ketoconazoleJournal of Antimicrobial Chemotherapy, 2001
- Effect of the alkyl-lysophospholipids on the proliferation and differentiation of Trypanosoma cruziActa Tropica, 2000
- The reservosome of Trypanosoma cruzi epimastigotes: an organelle of the endocytic pathway with a role on metacyclogenesisMemórias do Instituto Oswaldo Cruz, 1999
- The activities of four anticancer alkyllysophospholipids against Leishmania donovani, Trypanosoma cruzi and Trypanosoma bruceiJournal of Antimicrobial Chemotherapy, 1996
- Ultrastructural alterations induced by two ergosterol biosynthesis inhibitors, ketoconazole and terbinafine, on epimastigotes and amastigotes of Trypanosoma (Schizotrypanum) cruziAntimicrobial Agents and Chemotherapy, 1990
- Synergism between aminoglycosides and cephalosporins with antipseudomonal activity: interaction index and killing curve methodAntimicrobial Agents and Chemotherapy, 1982